The estimated Net Worth of Gaetan Michel is at least $149 Thousand dollars as of 24 August 2023. Gaetan Michel owns over 5,000 units of VolitionRX Ltd stock worth over $148,885 and over the last 6 years he sold VNRX stock worth over $0. In addition, he makes $0 as Chief Executive Officer of Belgian Volition at VolitionRX Ltd.
Sign up
Gaetan Michel VNRX stock SEC Form 4 insiders trading
Gaetan has made over 2 trades of the VolitionRX Ltd stock since 2020, according to the Form 4 filled with the SEC. Most recently he bought 5,000 units of VNRX stock worth $6,150 on 24 August 2023.
The largest trade he's ever made was buying 5,000 units of VolitionRX Ltd stock on 24 August 2023 worth over $6,150. On average, Gaetan trades about 625 units every 69 days since 2018. As of 24 August 2023 he still owns at least 212,997 units of VolitionRX Ltd stock.
You can see the complete history of Gaetan Michel stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Gaetan Michel biography
Dr. Gaetan Michel serves as Chief Executive Officer of Belgian Volition of the Company. Dr. Michel previously served as Belgian Volition’s Chief Operations Officer from July 2014 to June 2018. On January 10, 2020, Dr. Michel was also appointed the Managing Director of Volition Germany. Dr. Michel has over 10 years’ experience in production management. Prior to joining Belgian Volition, from 2010 to 2014 Dr. Michel worked as production director for Bone Therapeutics SA (Euronext Brussels and Paris: BOTHE), a bone cell therapy-based pharmaceutical company, where his responsibilities included establishing two new production plants to commence manufacturing for two phase III clinical trials, developing quality systems for new products in negotiation with the Belgian health authorities, and establishing a product plant for an injectable medical device. From 2007 to 2010, Dr. Michel worked for KitoZyme, a global manufacturer of biopolymers of fungal origin with its core business in weight management, digestive and cardiovascular health. During this period, Dr. Michel established both the production and process development departments and oversaw the commencement of the company’s industrial phase culminating in the roll out of first products. Prior to joining KitoZyme, following the completion of his PhD in 2002, Dr. Michel joined ATT (Advanced Array Technology), a University of Namur spin-off company as project manager in proteomics. ATT later became EAT (Eppendorf Array Technology), part of the German Eppendorf Biotech company, where Dr. Michel became production manager and was involved in establishing production processes and equipment. In light of Dr. Michel’s extensive experience in the area of production management, Dr. Michel was appointed as Chief Executive Officer of Belgian Volition.
How old is Gaetan Michel?
Gaetan Michel is 47, he's been the Chief Executive Officer of Belgian Volition of VolitionRX Ltd since 2015. There are 18 older and 2 younger executives at VolitionRX Ltd. The oldest executive at VolitionRX Ltd is Dr. Martin Charles Faulkes Ph.D., 77, who is the Exec. Chairman.
What's Gaetan Michel's mailing address?
Gaetan's mailing address filed with the SEC is 1489 WEST WARM SPRINGS ROAD, SUITE 110, HENDERSON, NV, 89014.
Insiders trading at VolitionRX Ltd
Over the last 12 years, insiders at VolitionRX Ltd have traded over $775,239 worth of VolitionRX Ltd stock and bought 1,908,474 units worth $44,487,770,972 . The most active insiders traders include Guy Archibald Innes, Cameron John Reynolds, and Martin Charles Faulkes. On average, VolitionRX Ltd executives and independent directors trade stock every 43 days with the average trade being worth of $27,899. The most recent stock trade was executed by Guy Archibald Innes on 20 August 2024, trading 150,000 units of VNRX stock currently worth $100,500.
What does VolitionRX Ltd do?
volitionrx is a life sciences company whose goal is to make its non-invasive blood tests for cancer as common and simple to use as existing diabetic and cholesterol tests on similar formats. volitionrx’s development activities are currently centered in belgium with a focus on bringing its revolutionary diagnostic products to market first in europe, then the u.s. and worldwide. you can find more information about volitionrx at our website at www.volitionrx.com, on twitter at www.twitter.com/volitionrx, linkedin at http://www.linkedin.com/company/volitionrx or facebook at www.facebook.com/volitionrx.
What does VolitionRX Ltd's logo look like?
Complete history of Gaetan Michel stock trades at VolitionRX Ltd
VolitionRX Ltd executives and stock owners
VolitionRX Ltd executives and other stock owners filed with the SEC include:
-
Cameron Reynolds,
President, Chief Executive Officer, Director -
Cameron Reynolds MBA,
Founder, Group CEO, Pres & Director -
Jason Terrell,
Chief Medical Officer and Head of US Operations -
Dr. Jason Bradley Terrell,
Chief Medical Officer & Head of U.S. Operations -
David Vanston,
Chief Financial Officer, Treasurer -
Jacob Micallef,
Chief Scientific Officer -
Martin Faulkes,
Executive Chairman of the Board -
Rodney Rootsaert,
Corporate Secretary -
Dr. Martin Charles Faulkes Ph.D.,
Exec. Chairman -
Dr. Jacob Vincent Micallef,
Chief Scientific Officer -
Dr. Salvatore Thomas Butera,
Chief Exec. Officer of Volition Veterinary Diagnostics Devel. LLC -
Scott Powell,
IR Contact Officer -
Guy Innes,
Independent Director -
Edward Futcher,
Independent Director -
Alan Colman,
Independent Director -
Phillip Barnes,
Independent Director -
Gaetan Michel,
Chief Executive Officer of Belgian Volition -
Jasmine Kway,
Chief Executive Officer of Singapore Volition -
Nick Plummer,
Group Gen. Counsel -
Scott Powell Ph.D.,
Exec. VP of Investor Relations & CFO of Volition America Inc -
Dr. Mark Eccleston M.B.A., Ph.D.,
Chief Technology Officer -
Dr. Gaetan Michel Ph.D.,
Chief Operating Officer -
Terig Hughes,
Group CFO & Treasurer -
Corp Ltd Cotterford Co Ltd ...,
-
Richard Brudnick,
-
Habib Skaff,
Director -
David Matthew Kratochvil,
Chief Financial Officer -
Rodney Gerard Concord Inter...,
Secretary -
Nicholas Plummer,
GC - Volition Diagnostics -
Ann Louise Batchelor,
Group Chief Marketing Officer -
Kim Nguyen,
-
Terig Hughes,
Chief Financial Officer -
Mickie Henshall,
-
Gael Forterre,
Chief Commercial Officer -
Corp Ltd Hever Investments ...,
-
Salvatore Thomas Butera,
CEO - Volition Veterinary